Ten representatives from European Cancer Registries have sent their candidature to the elections of the ENCR Steering Committee for the term 2024-2026.The CV and motivation letter from each candidate are available for consultation. The election… more
The Dutch Cancer Atlas, launched in January 2023 by the Netherlands Comprehensive Cancer Organisation (IKNL) is now available also in English.  The interactive online atlas shows geographical patterns in cancer… more
The new Quality Check Software Kit is now available for download. It includes the new QCS 2.1 and the latest version of the CVS Data Layout Converter, the tool used to check the compatibility of the incidence file format with the QCS according to the latest ENCR-… more
                    This User Insights Survey is part of the CanScreen-ECIS Project (EU4Health… more
The Organisation The National Cancer Registry is an essential part of Ireland’s efforts to successfully control cancer, reducing its impact on individuals, families and society. The National Cancer Registry (“NCRI”) was established by the Minister for Health in 1991 by Statutory Instrument and is … more
The research unit SESSTIM and its partners of the Challenges in the Estimation of Net SURvival (CENSUR) working survival Group offers an advanced course on statistical methods for excess risk analysis, at Corte, Université de Corse (France) from July 4th to 8th, 2022.
Last November 30th the Netherlands Comprehensive Cancer Organisation hosted the online symposium of the Netherlands Cancer Registry. The symposium focused on how to improve cancer care and prevention with insights from cancer registries. Cancer registries are the fuel for Europe’s Beating Cancer… more
The Comprehensive Cancer Organisation Netherlands (IKNL) invites all European Cancer Registries interested for an online symposium on the 30th of November.
The ENCR Scientific Meeting 2021 will be organised virtually this year, over three half-days.
The ENCR Scientific meeting will turn virtual in 2021 with three half-days on 16-17-18 November. We will soon publish the topics and dates for abstracts submission and conference registration.
JRC and ENCR organised on 5-6 June 2019 a training on Cancer Registry Data Coding at the JRC, Ispra, Italy. The agenda is available more
The course Statistical methods and recent advances in statistical methods for excess risk analysis will be held at Corte, Université de Corse (France) from 8-12 July 2019. This course is devoted to biostatisticians, statisticians, epidemiologists, researchers and students working in a registry of… more
The European Commission Joint Research Centre (JRC), the ENCR and EUROCARE organised a training on basic statistical analysis of cancer registry data from 5-6 June 2018 at the JRC Ispra, Italy. The aim of this course was to support the analysis of cancer registry data by describing the… more
The training on data coding, was organised jointly by the ENCR Steering Committee and the European Commission Joint Research Centre. The aim was to improve comparability and harmonisation, particularly on coding topography/morphology and stage.… more
JRC and ENCR organised on 3-4 May 2017 a training on Cancer Data Collection and Comparability with one day devoted to issues related to data collection, and the second day to quality aspects of data analysis. A specific session on childhood cancer registration was included. Basic principle… more
The JRC and the ENCR organised the 2016 ENCR Scientific Meeting and General Assembly, from 5-7 October in Baveno, Italy. The purpose of this bienial meeting was for European cancer registries to share research findings, discuss cancer registration issues, exchange ideas and best practices, network… more
31 August- 2 September 2016, London, UK This conference is co-organised by the Cancer Survival Group and the Centre for Statistical Methodology and will focus on three themes of time-to event analyses, all of which concentrate on population based data and translational epidemiology: Recent… more
1-4 November 2015, Liverpool (UK) The NCRI Cancer Conference will highlight the latest basic, translational and clinical cancer research. More information on the conference website.